• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统L中性氨基酸转运体在血脑屏障处的表达。

Expression of a system L neutral amino acid transporter at the blood-brain barrier.

作者信息

Matsuo H, Tsukada S, Nakata T, Chairoungdua A, Kim D K, Cha S H, Inatomi J, Yorifuji H, Fukuda J, Endou H, Kanai Y

机构信息

Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo Japan.

出版信息

Neuroreport. 2000 Nov 9;11(16):3507-11. doi: 10.1097/00001756-200011090-00021.

DOI:10.1097/00001756-200011090-00021
PMID:11095508
Abstract

Amino acid transport system L has been proposed to be one of the major nutrient transport systems at the blood-brain barrier. Using immunohistochemical analyses, a system L transporter LAT1 was shown to be expressed in the brain capillary endothelial cells in rats. Because LAT1 was coexpressed with 4F2 heavy chain which brings LAT1 to the plasma membrane, LAT1 is proposed to be functional in the plasma membrane of brain capillary endothelial cells. Both LAT1 and 4F2hc immunoreactivities were detected in a double line appearance surrounding endothelial cell nuclei, suggesting both proteins are present in the luminal and abluminal membranes. LAT1 is, thus, a blood-brain barrier system L transporter responsible for the permeation of aromatic or branched-chain amino acids and amino acid-related drugs such as L-DOPA.

摘要

氨基酸转运系统L被认为是血脑屏障处主要的营养物质转运系统之一。通过免疫组织化学分析,发现系统L转运体LAT1在大鼠脑毛细血管内皮细胞中表达。由于LAT1与将LAT1转运至质膜的4F2重链共表达,因此推测LAT1在脑毛细血管内皮细胞质膜中发挥功能。在内皮细胞核周围呈双线状出现LAT1和4F2hc免疫反应性,表明这两种蛋白均存在于管腔膜和管腔外膜中。因此,LAT1是一种血脑屏障系统L转运体,负责芳香族或支链氨基酸以及氨基酸相关药物(如左旋多巴)的通透。

相似文献

1
Expression of a system L neutral amino acid transporter at the blood-brain barrier.系统L中性氨基酸转运体在血脑屏障处的表达。
Neuroreport. 2000 Nov 9;11(16):3507-11. doi: 10.1097/00001756-200011090-00021.
2
The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.4F2hc/LAT1复合物可将左旋多巴转运穿过血脑屏障。
Brain Res. 2000 Oct 6;879(1-2):115-21. doi: 10.1016/s0006-8993(00)02758-x.
3
Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.大中性氨基酸转运体LAT1和LAT2的分子与功能鉴定及其在血脑屏障处的药理学意义
J Pharm Pharmacol. 2001 Apr;53(4):497-503. doi: 10.1211/0022357011775794.
4
Expression of large amino acid transporter LAT1 in rat brain endothelium.
J Cereb Blood Flow Metab. 2000 Nov;20(11):1557-62. doi: 10.1097/00004647-200011000-00005.
5
Selective expression of the large neutral amino acid transporter at the blood-brain barrier.大中性氨基酸转运体在血脑屏障处的选择性表达。
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12079-84. doi: 10.1073/pnas.96.21.12079.
6
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).由4F2抗原(CD98)重链激活的大中性氨基酸转运体的表达克隆与特性分析
J Biol Chem. 1998 Sep 11;273(37):23629-32. doi: 10.1074/jbc.273.37.23629.
7
Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.脑血管系统中大型中性氨基酸转运体(LAT1)亚型的主要功能活性。
Neurosci Lett. 2001 Jun 22;306(1-2):1-4. doi: 10.1016/s0304-3940(01)01810-9.
8
Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells.
J Neurochem. 2003 May;85(4):1037-42. doi: 10.1046/j.1471-4159.2003.01757.x.
9
Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.人神经胶质瘤中 L-甲基-11C-蛋氨酸(MET)摄取与 L 型氨基酸转运体 1 的相关性。
J Neurooncol. 2010 Sep;99(2):217-25. doi: 10.1007/s11060-010-0117-9. Epub 2010 Jan 21.
10
Up-regulation of L-type amino acid transporter 1 (LAT1) in cultured rat retinal capillary endothelial cells in response to glucose deprivation.葡萄糖剥夺对培养的大鼠视网膜毛细血管内皮细胞中 L 型氨基酸转运蛋白 1(LAT1)的上调作用。
Drug Metab Pharmacokinet. 2012;27(3):317-24. doi: 10.2133/dmpk.dmpk-11-rg-122. Epub 2011 Dec 20.

引用本文的文献

1
Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy.对选择性LAT1(SLC7A5)抑制剂纳武单抗及其N-乙酰代谢物的药理学和结构见解及其对癌症治疗的意义。
Sci Rep. 2025 Jan 23;15(1):2903. doi: 10.1038/s41598-025-87522-6.
2
Amino acid transporter LAT1 is expressed on cancer cell-derived exosomes with potential as a diagnostic and prognostic biomarker.氨基酸转运蛋白 LAT1 表达在癌细胞衍生的外泌体上,具有作为诊断和预后生物标志物的潜力。
Sci Rep. 2024 Nov 18;14(1):28458. doi: 10.1038/s41598-024-79425-9.
3
The Multifaceted Role of L-Type Amino Acid Transporter 1 at the Blood-Brain Barrier: Structural Implications and Therapeutic Potential.
L型氨基酸转运体1在血脑屏障中的多方面作用:结构意义与治疗潜力
Mol Neurobiol. 2025 Mar;62(3):3813-3832. doi: 10.1007/s12035-024-04506-9. Epub 2024 Sep 26.
4
Structure-activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1).L 型氨基酸转运体 1(LAT1)选择性转运的苯丙氨酸类似物的结构-活性特征。
Sci Rep. 2024 Feb 26;14(1):4651. doi: 10.1038/s41598-024-55252-w.
5
The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.人 LAT1-4F2hc(SLC7A5-SLC3A2)转运体复合物:生理和病理生理学意义。
Basic Clin Pharmacol Toxicol. 2023 Nov;133(5):459-472. doi: 10.1111/bcpt.13821. Epub 2022 Dec 13.
6
Blood-Brain Barrier Solute Carrier Transporters and Motor Neuron Disease.血脑屏障溶质载体转运体与运动神经元病
Pharmaceutics. 2022 Oct 11;14(10):2167. doi: 10.3390/pharmaceutics14102167.
7
Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells.药物抑制 LAT1 主要抑制大中性氨基酸的转运,并下调癌细胞中的全局翻译。
J Cell Mol Med. 2022 Oct;26(20):5246-5256. doi: 10.1111/jcmm.17553. Epub 2022 Sep 7.
8
Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.外泌体靶向递送至脑的策略:优势与挑战
Pharmaceutics. 2022 Mar 18;14(3):672. doi: 10.3390/pharmaceutics14030672.
9
A Novel Blood-Brain Barrier-Permeable Chemotherapeutic Agent for the Treatment of Glioblastoma.一种用于治疗胶质母细胞瘤的新型血脑屏障可渗透化疗药物。
Cureus. 2021 Aug 31;13(8):e17595. doi: 10.7759/cureus.17595. eCollection 2021 Aug.
10
Characteristics of F-FDG and F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1.8 岁已绝育雄性约克夏梗犬脑胶质瘤的 F-FDG 和 F-FDOPA PET 特征:用羟基脲联合伊马替尼、泼尼松进行长期化疗及 PDGFR-β和 LAT1 的免疫反应性。
Vet Q. 2021 Dec;41(1):163-171. doi: 10.1080/01652176.2021.1906466.